Correction to Adiposity 101
Author |
Message |
Chuck Forsberg WA7K #1 / 32
|
 Correction to Adiposity 101
Some editions of Adiposity 101 discuss the association between high concentrations of insulin in the fetus' amniotic fluid and subsequent obesity. This information first became available in news reports that concentrated on insulin in the amniotic fluid. It was reported that some researchers thought the obesity was *caused* by the high concentration of insulin in the amniotic fluid. This implied the mother's insulin was leaking into the amniotic fluid. A subsequent examination of the papers indicates the authors do not believe mother's insulin leaks into the amniotic fluid, or any other part of the fetus. Apparently, there is no special significance to the level of insulin in the amniotic fluid beyond the (very important!) fact that it presents the only practical way to estimate plasma insulin levels in the fetus. What's the bottom line of all this? That many cases of obesity and eventual diabetes have their beginnings before birth as hyperinsulinaemia and insulin resistance reveal the body's inability to adequately control plasma glucose. -- Chuck Forsberg WA7KGX ...!tektronix!reed!omen!caf Author of YMODEM, ZMODEM, Professional-YAM, ZCOMM, and DSZ Omen Technology Inc "The High Reliability Software" 17505-V NW Sauvie IS RD Portland OR 97231 503-621-3406
|
Fri, 28 Jul 1995 04:14:45 GMT |
|
 |
Gordon Ban #2 / 32
|
 Correction to Adiposity 101
Quote: >What's the bottom line of all this? That many cases of obesity >and eventual diabetes have their beginnings before birth as >hyperinsulinaemia and insulin resistance reveal the body's >inability to adequately control plasma glucose.
Could well be, Chuck. Perhaps you will need to modify the hypothesis that it is caused by the diet industry. I suspect there is a genetic factor, possibly related to the ability of the obese to survive famine and possibly for obese women to survive pregnancy, especially in climates with long winters, like northern and eastern Europe. Now that cooking.net">food is abundant, those of us who inherited such genes are at a disadvantage, rather than an advantage. -- --------------------------------------------------------------------------- - Gordon Banks N3JXP | "Skepticism is the chastity of the intellect, and
----------------------------------------------------------------------------
|
Sun, 06 Aug 1995 23:28:43 GMT |
|
 |
Chuck Forsberg WA7K #3 / 32
|
 Correction to Adiposity 101
Quote:
>>What's the bottom line of all this? That many cases of obesity >>and eventual diabetes have their beginnings before birth as >>hyperinsulinaemia and insulin resistance reveal the body's >>inability to adequately control plasma glucose. >Could well be, Chuck. Perhaps you will need to modify >the hypothesis that it is caused by the diet industry. >I suspect there is a genetic factor, possibly related >to the ability of the obese to survive famine and >possibly for obese women to survive pregnancy, especially >in climates with long winters, like northern and eastern Europe.
Pima Indians and Australian Aborigines have been identified in papers I've read as having a high incidence of this syndrome compared to Caucasians. It seems reasonable to suspect a strong genetic component. However, injecting insulin into normal rats has been shown to make them fat. High fetal insulin levels predict later fatness, even when the parents' obesity is factored. So these studies indicate a carbohydrate-driven environmental influence, alebit one that is difficult to distinguish from genetic influence. Quote: >Now that cooking.net">food is abundant, those of us who >inherited such genes are at a disadvantage, rather than >an advantage. The genetic ability to deal with today's high dietary carbohydrate levels is quite useful. Maybe the FDA will finally get off its duff and approve {*filter*} that improve insulin sensitivity (gliclazide, metformin, etc.) as treatments for insulin insensitivity instead of the old {*filter*} that boost insulin secretion instead of treating insulin insensitivity. -- Chuck Forsberg WA7KGX ...!tektronix!reed!omen!caf Author of YMODEM, ZMODEM, Professional-YAM, ZCOMM, and DSZ Omen Technology Inc "The High Reliability Software" 17505-V NW Sauvie IS RD Portland OR 97231 503-621-3406
|
Mon, 07 Aug 1995 19:33:11 GMT |
|
 |
Herman Rub #4 / 32
|
 Correction to Adiposity 101
Quote:
>>>What's the bottom line of all this? That many cases of obesity >>>and eventual diabetes have their beginnings before birth as >>>hyperinsulinaemia and insulin resistance reveal the body's >>>inability to adequately control plasma glucose.
...................... Quote: >The genetic ability to deal with today's high dietary >carbohydrate levels is quite useful. >Maybe the FDA will finally get off its duff and approve {*filter*} that >improve insulin sensitivity (gliclazide, metformin, etc.) as treatments >for insulin insensitivity instead of the old {*filter*} that boost insulin >secretion instead of treating insulin insensitivity.
The FDA was not in favor of such {*filter*} either, and only the legal requirement that the studies on which their banning is based be published kept them from banning the {*filter*}{*filter*} stated above. The study that they wanted to use was panned very badly on what was known about it. -- Herman Rubin, Dept. of Statistics, Purdue Univ., West Lafayette IN47907-1399 Phone: (317)494-6054
{purdue,pur-ee}!snap.stat!hrubin(UUCP)
|
Wed, 09 Aug 1995 04:29:34 GMT |
|
 |
Chuck Forsberg WA7K #5 / 32
|
 Correction to Adiposity 101
Quote:
>>>>What's the bottom line of all this? That many cases of obesity >>>>and eventual diabetes have their beginnings before birth as >>>>hyperinsulinaemia and insulin resistance reveal the body's >>>>inability to adequately control plasma glucose. > ...................... >>The genetic ability to deal with today's high dietary >>carbohydrate levels is quite useful. >>Maybe the FDA will finally get off its duff and approve {*filter*} that >>improve insulin sensitivity (gliclazide, metformin, etc.) as treatments >>for insulin insensitivity instead of the old {*filter*} that boost insulin >>secretion instead of treating insulin insensitivity. >The FDA was not in favor of such {*filter*} either, and only the legal >requirement that the studies on which their banning is based be published >kept them from banning the {*filter*}{*filter*} stated above. The study that they >wanted to use was panned very badly on what was known about it.
So why is the FDA so hostile to {*filter*} that improve insulin sensitivity (gliclazide, metformin, etc.)??? The second generation {*filter*} have been in use world wide for 20 years. Unlike the {*filter*} currently available in the U.S., Diamicron restores a physiological insulin response, avoids hyperinsulnism, prevents weight gain, allows diet-induced weight reduction, reduces hyperadhesiveness, hyperaggregation, and diabetic retinopathy. By avoiding hyperinsulinemia, Diamicron eliminates a major atheroscl{*filter*} risk. Diamicron is used in over 100 countries worldwide. Metformin has been used in Canada for 20 years without a single reported case of metformin-induced lactic acidosis. How many of my parents' friends who died of complications of diabetes would have been alive today if they had moved to Canada and its "inferior" medical system??? -- Chuck Forsberg WA7KGX ...!tektronix!reed!omen!caf Author of YMODEM, ZMODEM, Professional-YAM, ZCOMM, and DSZ Omen Technology Inc "The High Reliability Software" 17505-V NW Sauvie IS RD Portland OR 97231 503-621-3406
|
Thu, 10 Aug 1995 01:48:09 GMT |
|
 |
Steve Dy #6 / 32
|
 Correction to Adiposity 101
Quote: >So why is the FDA so hostile to {*filter*} that improve insulin >sensitivity (gliclazide, metformin, etc.)??? The second >generation {*filter*} have been in use world wide for 20 years.
Actually, you can obtain phenformin (the 1st generation biguanide which was withdrawn from the market in 1978) on an investigational NDA from the FDA. Have your doctor contact Ciba-Geigy for the details of the protocol. It wasn't a miracle drug while it still was being sold; there's no reason to expect it's any more wonderful now. Quote: >Unlike the {*filter*} currently available in the U.S., Diamicron >restores a physiological insulin response, avoids >hyperinsulnism, prevents weight gain, allows diet-induced weight >reduction, reduces hyperadhesiveness, hyperaggregation, and >diabetic retinopathy. By avoiding hyperinsulinemia, Diamicron >eliminates a major atheroscl{*filter*} risk.
I don't know what's so special about gliclazide; it's just yet another sulfonylurea. Yawn. Quote: >Diamicron is used in over 100 countries worldwide. Metformin has >been used in Canada for 20 years without a single reported case of >metformin-induced lactic acidosis. >How many of my parents' friends who died of complications of >diabetes would have been alive today if they had moved to Canada >and its "inferior" medical system???
Probably none of them. One of your problems, Chuck, is that you're much too credulous when it comes to reading claims for {*filter*} which aren't easily available to you. A little skepticism when reading adverti{*filter*}ts _and_ scientific papers would go a long way. Like I said before, you live in Portland--take a day trip to Vancouver BC and talk to a diabetes specialist there who can tell you about his clinical experience with metformin. I'm sure s/he'll be much less impressed than you are. But if you really want to try it, you can probably get an Rx in Canada. And from there I'm sure your enthusiasm will inevitably wane, as you find that you aren't losing weight miraculously. Another issue is that you ascribe powers to {*filter*} whose effects on weight are orders of magnitude weaker than actions you yourself can take. Being prescribed a sulfonylurea to control your insulin levels is not by itself going to keep anybody fat, even if you're suffering from hyperinsulinemia and insulin resistance. -- Steve Dyer
|
Thu, 10 Aug 1995 02:29:58 GMT |
|
 |
Howard R Doy #7 / 32
|
 Correction to Adiposity 101
[a lot of stuff deleted] Quote: >So why is the FDA so hostile to {*filter*} that improve insulin >sensitivity (gliclazide, metformin, etc.)??? The second >generation {*filter*} have been in use world wide for 20 years. >Unlike the {*filter*} currently available in the U.S., Diamicron >restores a physiological insulin response, avoids >hyperinsulnism, prevents weight gain, allows diet-induced weight >reduction, reduces hyperadhesiveness, hyperaggregation, and >diabetic retinopathy. By avoiding hyperinsulinemia, Diamicron >eliminates a major atheroscl{*filter*} risk.
Wow, a miracle drug. Is there a downside to this Eighth Wonder? ======================================== Howard Doyle
have you hugged your organ donor card today?
|
Thu, 10 Aug 1995 02:32:09 GMT |
|
 |
#8 / 32
|
 Correction to Adiposity 101
|
Fri, 19 Jun 1992 00:00:00 GMT |
|
 |
Herman Rub #9 / 32
|
 Correction to Adiposity 101
Quote:
>>>>>What's the bottom line of all this? That many cases of obesity >>>>>and eventual diabetes have their beginnings before birth as >>>>>hyperinsulinaemia and insulin resistance reveal the body's >>>>>inability to adequately control plasma glucose. >> ...................... >>>The genetic ability to deal with today's high dietary >>>carbohydrate levels is quite useful. >>>Maybe the FDA will finally get off its duff and approve {*filter*} that >>>improve insulin sensitivity (gliclazide, metformin, etc.) as treatments >>>for insulin insensitivity instead of the old {*filter*} that boost insulin >>>secretion instead of treating insulin insensitivity. >>The FDA was not in favor of such {*filter*} either, and only the legal >>requirement that the studies on which their banning is based be published >>kept them from banning the {*filter*}{*filter*} stated above. The study that they >>wanted to use was panned very badly on what was known about it. >So why is the FDA so hostile to {*filter*} that improve insulin >sensitivity (gliclazide, metformin, etc.)???
The study I mentioned was only for diabinese, and claimed to have a somewhat higher proportion of cardiac deaths. The FDA argued, according to the statements which I read many years ago in _Science_, that these {*filter*} were no more effective than diet and exercise, with resorting to insulin if necessary. The second Quote: >generation {*filter*} have been in use world wide for 20 years. >Unlike the {*filter*} currently available in the U.S., Diamicron >restores a physiological insulin response, avoids >hyperinsulnism, prevents weight gain, allows diet-induced weight >reduction, reduces hyperadhesiveness, hyperaggregation, and >diabetic retinopathy. By avoiding hyperinsulinemia, Diamicron >eliminates a major atheroscl{*filter*} risk. >Diamicron is used in over 100 countries worldwide. Metformin has >been used in Canada for 20 years without a single reported case of >metformin-induced lactic acidosis. >How many of my parents' friends who died of complications of >diabetes would have been alive today if they had moved to Canada >and its "inferior" medical system???
My sister died of this, and until her kidneys failed she was considered to be in good control by the {*filter*}medication. I seem to have avoided major complications so far, but who knows? It is not the medical system so much as the absence of a paranoid FDA. This paranoia is pushed by those who believe that the FDA would be involved in causing death ar injury from an adverse reaction, but that not approving treatments quickly enough does not reflect on the FDA, but upon the drug companies for not coming up with "safe, effective" chemicals. Remember the fuss about Alar-treated apples recently? At least one quite well-respected scientist in the area of chemical and bacteriological problems has claimed that Alar prevented more cancer by reducing bruising than it caused. Bruising of fruit and vegetables produces toxins and carcinogens. -- Herman Rubin, Dept. of Statistics, Purdue Univ., West Lafayette IN47907-1399 Phone: (317)494-6054
{purdue,pur-ee}!snap.stat!hrubin(UUCP)
|
Thu, 10 Aug 1995 04:15:25 GMT |
|
 |
#10 / 32
|
 Correction to Adiposity 101
|
Fri, 19 Jun 1992 00:00:00 GMT |
|
 |
Gordon Ban #11 / 32
|
 Correction to Adiposity 101
Quote: >Maybe the FDA will finally get off its duff and approve {*filter*} that >improve insulin sensitivity (gliclazide, metformin, etc.) as treatments >for insulin insensitivity instead of the old {*filter*} that boost insulin >secretion instead of treating insulin insensitivity.
But if the problem begins in-utero, it would seem that what we really need is research to identify mothers-at-risk of having obesity-prone children and find some way of treating them during the pregnancy to prevent it. I suspect that there will still be cases where the obesity is genetic and not an influence on the embryo. In my own family, the obesity came from my father's side, where all my massively obese relatives are. It is hard to see where an in-utero influence from my mother had much to do with it. From the pedigree charts, it looks to me like an autosomal {*filter*} gene, with about 50% of the children getting it and 50% having little or no tendancy to get obese. -- ---------------------------------------------------------------------------- Gordon Banks N3JXP | "Skepticism is the chastity of the intellect, and
----------------------------------------------------------------------------
|
Fri, 11 Aug 1995 22:31:48 GMT |
|
 |
#12 / 32
|
 Correction to Adiposity 101
|
Fri, 19 Jun 1992 00:00:00 GMT |
|
 |
Robert Greenste #13 / 32
|
 Correction to Adiposity 101
Quote:
>Remember the fuss about Alar-treated apples recently? At least >one quite well-respected scientist in the area of chemical and >bacteriological problems has claimed that Alar prevented more >cancer by reducing bruising than it caused. Bruising of fruit >and vegetables produces toxins and carcinogens.
So one "well-respected scientist" says this? Who is he? Wouldn't be UC Berkeley's Bruce Ames, by any chance? His name always crops up in these discussions. He is nothing more than a paid apologist for the agrichemical industry. -- *************************************************************************** *** Robert Greenstein What the fool cannot learn he laughs at, thinking
of latent idiocy - M. Corelli
|
Sat, 12 Aug 1995 04:49:33 GMT |
|
 |
#14 / 32
|
 Correction to Adiposity 101
|
Fri, 19 Jun 1992 00:00:00 GMT |
|
 |
Chuck Forsberg WA7K #15 / 32
|
 Correction to Adiposity 101
Quote:
>>So why is the FDA so hostile to {*filter*} that improve insulin >>sensitivity (gliclazide, metformin, etc.)??? The second >>generation {*filter*} have been in use world wide for 20 years. >Actually, you can obtain phenformin (the 1st generation biguanide >which was withdrawn from the market in 1978) on an investigational >NDA from the FDA. Have your doctor contact Ciba-Geigy for the >details of the protocol. It wasn't a miracle drug while it still >was being sold; there's no reason to expect it's any more wonderful now.
Phenformin has a risk of .64/1000 patients per year of of lactic acidosis. I don't know much about lactic acidosis but it sounds dreadful and is life threating. It may have something to do with the fact that adipose cells convert glucose into lactate. Metformin reduces this risk to 0.05 cases/1000 patients/year, somewhat better odds. Quote: >>Unlike the {*filter*} currently available in the U.S., Diamicron >>restores a physiological insulin response, avoids >>hyperinsulnism, prevents weight gain, allows diet-induced weight >>reduction, reduces hyperadhesiveness, hyperaggregation, and >>diabetic retinopathy. By avoiding hyperinsulinemia, Diamicron >>eliminates a major atheroscl{*filter*} risk. >I don't know what's so special about gliclazide; it's just yet >another sulfonylurea. Yawn.
Most sulfonylureas do not decrease insulin resistance, they just increase the production of insulin. Hyperinsulnism causes weight gain. The cardiac problems associated with diabetes appear to be caused by hyperinsulinemia and not hyperglycaemia, so sulfonylureas may make this problem worse, not better. Metformin does not increase insulin production. In fact it does not reduce glucose in healthy subjects, and is not known to cause hypoglycaemia. Gliclazide is a sulfonylurea, but one that seems to behave more like metformin. If you have information that refutes this, let's see something more than a yawn. Don't forget, if you have a weight problem, particularly if you've ever "flunked" a GTT, chances are this will in time become a concern. Quote: >>Diamicron is used in over 100 countries worldwide. Metformin has >>been used in Canada for 20 years without a single reported case of >>metformin-induced lactic acidosis. >>How many of my parents' friends who died of complications of >>diabetes would have been alive today if they had moved to Canada >>and its "inferior" medical system??? >Probably none of them.
They may have died of the atheroscl{*filter*} complications of diabetes because their insulin levels were not controlled. Quote: >One of your problems, Chuck, is that you're much too credulous >when it comes to reading claims for {*filter*} which aren't easily >available to you. A little skepticism when reading adverti{*filter*}ts >_and_ scientific papers would go a long way. Like I said before,
I mentioned the advert because it concisely states the case for {*filter*} that control insulin resistance instead of {*filter*} that simply boot insulin secretion. I've read quite a few papers on the subject recently, and many more abstracts, and none of them have contradicted the distinctions between the stuff Kaiser has me on and metformin. Quote: >you live in Portland--take a day trip to Vancouver BC and talk to >a diabetes specialist there who can tell you about his clinical >experience with metformin. I'm sure s/he'll be much less impressed >than you are. But if you really want to try it, you can probably >get an Rx in Canada. And from there I'm sure your enthusiasm will >inevitably wane, as you find that you aren't losing weight miraculously.
Vanvouver BC is too far away for a day trip thanks to US Customs and the Washington State Highway Patrol. But it's a thought. Metformin is prescribed for quite a few cases. None of these {*filter*} seems in any way miraculous. But it shouldn't be too much to ask for a drug that is used world-wide (phenformin isn't anymore) that reduces excessive insulin levels. Quote: >Another issue is that you ascribe powers to {*filter*} whose effects >on weight are orders of magnitude weaker than actions you yourself >can take. Being prescribed a sulfonylurea to control your insulin >levels is not by itself going to keep anybody fat, even if you're >suffering from hyperinsulinemia and insulin resistance.
Weight gain seems to be the most common side-effect of diabetes {*filter*} that boost insulin. I didn't ask for a magic thin pill, just something that doesn't work against me. -- Chuck Forsberg WA7KGX ...!tektronix!reed!omen!caf Author of YMODEM, ZMODEM, Professional-YAM, ZCOMM, and DSZ Omen Technology Inc "The High Reliability Software" 17505-V NW Sauvie IS RD Portland OR 97231 503-621-3406
|
Sat, 12 Aug 1995 20:58:22 GMT |
|
|
Page 1 of 3
|
[ 32 post ] |
|
Go to page:
[1]
[2] [3] |
|